European Journal of Cancer and Clinical Oncology
Volume 24, Issue 1, January 1988, Pages 29-43
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
References (107)
- et al.
Breast carcinoma etiological factors
Adv Cancer Res
(1983) - et al.
Variations in mortality by weight among 750,000 men and women
J Chron Dis
(1979) - et al.
Proliferation kinetics of human endometrium during the normal menstrual cycle
Am J Obstet Gynecol
(1979) - et al.
Oestrogens and endometrial cancer: effect of other risk factors on the association
Maturitas
(1980) - et al.
Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel
Am J Obstet Gynecol
(1977) Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine
Human Pathol
(1977)- et al.
Urinary excretion of estrone, estradiol, and estriol by patients with breast cancer and benign breast disease
Am J Obstet Gynecol
(1965) - et al.
Urinary excretion of neutral 17-ketosteroids and pregnanediol by patients with breast cancer and benign breast disease
Am J Obstet Gynecol
(1965) - et al.
Lancet
(1973) - et al.
Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast
Eur J Cancer Clin Oncol
(1983)
Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer
Eur J Cancer
(1968)
Androgens in breast cancer
Am J Obstet Gynecol
(1974)
Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens
J Steroid Biochem
(1975)
Plasma hormones in pre- and postmenopausal breast cancer
J Steroid Biochem
(1980)
Circulating hormone concentrations in women with breast cancer
Lancet
(1976)
Plasma testosterone and breast cancer
Eur J Cancer Clin Oncol
(1985)
Breast cancer and estrogen replacement therapy
Am J Obstet Gynecol
(1982)
Menopausal estrogen use and the risk of breast cancer
Breast Cancer Res Treat
(1986)
The association of depot-medroxyprogesterone acetate and breast cancer
Contraception
(1980)
A review of the epidemiology of human breast cancer
Epidemiol Rev
(1979)
Evidence for a crossover in breast cancer risk factors
Am J Epidemiol
(1982)
A prospective study in general practice on breast-cancer risk in postmenopausal women
Int J Cancer
(1974)
Exogenous estrogens and other factors in the epidemiology of breast cancer
J Natl Cancer Inst
(1981)
Overweight and changes in weight throughout adult life in breast cancer etiology
Am J Epidemiol
(1985)
Relative weight and risk of breast cancer among premenopausal women
Am J Epidemiol
(1985)
Cyclic ovarian function and breast cancer
Cancer Res (Suppl)
(1982)
Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease
J Natl Cancer Inst
(1983)
Menstrual cycle patterns and the risk of breast disease
Eur J Cancer Clin Oncol
(1985)
Cancer of the corpus uteri
The menstrual cycle
Endogenous hormones as a major factor in human cancer
Cancer Res
(1982)
Steroid hormones and endometrial cancer
Cancer Res
(1978)
The epidemiology of endometrial cancer in young women
Br J Cancer
(1983)
Obesity, androgens, estrogens, and cancer risk
Cancer Res (Suppl)
(1982)
Relationship of obesity to blood estrogens
Cancer Res (Suppl)
(1982)
The relation of obesity to menstrual disturbances
N Engl J Med
(1952)
Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase
J Clin Endocrinol Metabol
(1974)
The association of girth measurements with disease in 32,856 women
Am J Epidemiol
(1984)
Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk
J Clin Endocrinol Metab
(1981)
Morphological evaluation of cell turnover in relation to the menstrual cycle in the ‘resting’ human breast
Br J Cancer
(1981)
Cell turnover in the ‘resting’ human breast: influence of parity, contraceptive pill, age and laterality
Br J Cancer
(1982)
A correlative morphologic study of human breast and endometrium in the menstrual cycle
Am J Surg Pathol
(1986)
Cyclical variations of DNA synthesis in human breast epithelium
J Natl Cancer Inst
(1977)
The correlation of histologic changes in the human breast with the menstrual cycle
Am J Pathol
(1981)
The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice
Cancer
(1984)
Oral contraceptives and breast cancer
Cancer
(1987)
Antiestrogen action of progesterone in breast tissue
Breast Cancer Res Treat
(1986)
Oophorectomy and cortisone treatment as a method of eliminating oestrogen production in patients with breast cancer
Acta Endocrinol
(1964)
Hormonal status of breast cancer. III. Further analysis of ovarian-adrenal dysfunction
J Natl Cancer Inst
(1977)
Cited by (604)
Contributions of twin studies to cancer epidemiology
2022, Twin Research for Everyone: From Biology to Health, Epigenetics, and PsychologyGut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens
2019, Journal of Biological ChemistryCitation Excerpt :Upon entry into the GI tract, they are exposed to GUS enzymes that could, in theory, cleave the sugar moiety, reactivating the parent compound and allowing the unconjugated estrogen to be reabsorbed in the bloodstream and undergo iterative rounds of enterohepatic recirculation (18, 19). This is potentially significant in oncology, as there is now general agreement that the concentrations of unbound estrogens are much higher in plasma and tissues of women with hormone-driven cancers (20–23). Therefore, an estrobolome enriched in β-glucuronidase enzymes that promote estrogen metabolite deconjugation reactions may result in greater reabsorption of free estrogens and a greater risk of hormone receptor–positive (HR +) cancers (Fig. 1).
Neutering in dogs and cats: Current scientific evidence and importance of adequate nutritional management
2020, Nutrition Research ReviewsAssociation of physical weight statuses defined by body mass index (BMI) with molecular subtypes of premenopausal breast cancer: a systematic review and meta-analysis
2024, Breast Cancer Research and Treatment
Copyright © 1988 Published by Elsevier Ltd.